NYT has an article on the first randomized clinical trial for TRT with men 65 and older, as reported in the New England Journal of Medicine. It’s a study done with topical gel (AndroGel) and no co-therapies, and addresses only normal age-related decline in T-levels.
The lukewarm NYT spin is that benefits to sexual function and physical stamina are “modest” at best. The article strikes a cautionary and dismissive tone overall, with one quoted authority calling for a “more conservative approach” to TRT. No mention of best practices or alternatives like injection vs gel, AI to keep estradiol at bay. I’ll be interested to hear what our resident gurus think of this study.